See also: GLP-1 Guides | Provider Comparisons BPC-157 doses in research typically range from 200 to 800 mcg per day, given once or twice daily by subcutaneous injection or oral capsule
A 2025 systematic review in Orthopaedic Sports Medicine analyzed 36 studies on BPC-157 and found that the peptide improved functional, structural, and biomechanical outcomes in muscle, tendon, ligament, and bone injury models
Prioritize GHK-Cu if: You're primarily concerned with visible wrinkles, skin laxity, photodamage, post-procedure recovery, or compromised barrier function
According to NICE Clinical Knowledge Summaries, once B12 deficiency is adequately treated and symptoms resolve, routine monitoring of serum B12 levels is generally unnecessary, as clinical response is the primary indicator of treatment effectiveness
The combination of GLP-1 and GIP activation is what separates tirzepatide from pure GLP-1 agonists like semaglutide, and clinical data suggests the dual mechanism produces superior weight loss outcomes